Jul 26, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
It’s no lie the drug development model is in need of a drastic shakeup. With lengthy and costly approval processes, generic incursion, rising development costs and the need for novel adherence strategies, pharma and biotech, now more than ever need to initiate...
Sep 13, 2019 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Beyond 2020, the global Peptide Therapeutics market is expected to eclipse $42 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include...
Nov 18, 2015 | Main Blog |
Today, I had the pleasure of speaking with the great Chris Brogan (CEO of Owner Media Group, marketing genius and the NY Times bestselling author). Chris has kindly agreed to keynote our forthcoming MedDev eMarketing Summit in San Diego, next February. “You live or...
Recent Comments